Do elevated branched-chain keto acids cluster with insulin resistance and impaired fuel handling?

Elevated circulating branched-chain keto acids (BCKAs)—specifically ketoisocaproic acid, ketoisovaleric acid, and keto-beta-methylvaleric acid—are key metabolomic markers and active drivers of metabolic dysfunction, strongly clustering with insulin resistance and compromised energy homeostasis.

Clinical and metabolic associations

• Metabolomic profiling demonstrates that elevated circulating BCKAs closely track with HOMA-IR signatures, serving as robust biomarkers for insulin resistance and type 2 diabetes.
• High systemic levels of BCKAs strongly cluster with impaired fuel handling, wherein metabolic tissues exhibit compromised nutrient clearance, mitochondrial fuel overload, and reduced metabolic flexibility.

Mechanistic explanations

• mTORC1-mediated insulin resistance: Elevated BCKAs, particularly ketoisocaproic acid, directly stimulate mTORC1 and downstream S6K1 signaling in skeletal muscle. This hyperactivation drives the inhibitory serine phosphorylation of insulin receptor substrate 1 (IRS-1), which blunts downstream insulin signaling and impairs insulin-stimulated glucose transport.
• Mitochondrial dysfunction and impaired fuel handling: Excess BCKAs suppress the expression of succinate dehydrogenase, disrupting tricarboxylic acid (TCA) cycle flux. This suppression triggers mitochondrial dysfunction, anaplerotic stress, and defective oxidative metabolism, resulting in impaired pyruvate handling and a pathological feed-forward loop of nutrient congestion.

Bottom line

• Elevated BCKAs (ketoisocaproic, ketoisovaleric, and keto-beta-methylvaleric acids) are highly correlated with metabolic dysfunction, acting as direct cellular stressors that impair insulin-stimulated glucose uptake and disrupt mitochondrial oxidative pathways.